Thrivent Financial for Lutherans’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $22.8M | Sell |
|
|||||
|
2021
Q3 | $33.4M | Buy |
|
|||||
|
2021
Q2 | $44.6M | Buy |
|
|||||
|
2021
Q1 | $36M | Buy |
|
|||||
|
2020
Q4 | $39.6M | Sell |
|
|||||
|
2020
Q3 | $35.3M | Sell |
|
|||||
|
2020
Q2 | $31.1M | Buy |
|
|||||
|
2020
Q1 | $8.44M | Buy |
|
|||||
|
2019
Q4 | $6.09M | Buy |
|
|||||
|
2019
Q3 | $3.98M | Buy |
|
|||||
|
2019
Q2 | $2.92M | Buy |
|
|||||
|
2019
Q1 | $2.78M | Sell |
|
|||||
|
2018
Q4 | $3.27M | Sell |
|
|||||
|
2018
Q3 | $9.25M | Sell |
|
|||||
|
2018
Q2 | $14.5M | Sell |
|
|||||
|
2018
Q1 | $18.4M | Buy |
|
|||||
|
2017
Q4 | $14.5M | Hold |
|
|||||
|
2017
Q3 | $19.1M | Hold |
|
|||||
|
2017
Q2 | $15.7M | Buy |
|
|||||
|
2017
Q1 | $18.8M | Buy |
|
|||||
|
2016
Q4 | $14M | Buy |
|
|||||
|
2016
Q3 | $15.3M | Buy |
|
|||||
|
2016
Q2 | $9.54M | Buy |
|
|||||
|
2016
Q1 | $6.07M | Buy |
|